JAMEL REYNOLDS: Open Payments
NPI 1720605033 · LIBERTY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,690 in 75 payments from 26 companies in 2025. Trend: 2023 $552 · 2024 $653 · 2025 $1,690
Food & beverage: $1,690
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $304 |
| ABBVIE INC. | 10 | $183 |
| PFIZER INC. | 13 | $170 |
| Phathom Pharmaceuticals, Inc. | 2 | $168 |
| Novo Nordisk Inc | 11 | $146 |
| Lilly USA, LLC | 4 | $78 |
| Organon LLC | 2 | $59 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Ardelyx, Inc. | 2 | $51 |
Products named: FARXIGA, VOQUEZNA, Ozempic, NURTEC ODT, UBRELVY, VRAYLAR, MOUNJARO, ELIQUIS.
Industry payments across MO — which companies pay providers there.
